Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;6(5):336-337.
doi: 10.1016/S2468-1253(21)00063-7. Epub 2021 Mar 19.

Prevention of post-ERCP pancreatitis: the search continues

Jeffrey J Easler  1 , Evan L Fogel  2
Affiliations
Comment

Prevention of post-ERCP pancreatitis: the search continues

Jeffrey J Easler et al. Lancet Gastroenterol Hepatol. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52: 127–49. - PubMed
    1. Chandrasekhara V, Khashab MA, Muthusamy VR, et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32–47. - PubMed
    1. Pekgoz M Post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review for prevention and treatment. World J Gastroenterol 2019; 25: 4019–42. - PMC - PubMed
    1. Radadiya D, Devani K, Arora S, et al. Peri-procedural aggressive hydration for post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis prophylaxsis: meta-analysis of randomized controlled trials. Pancreatology 2019; 19: 819–27. - PubMed
    1. Sperna Weiland CJ, Smeets XJNM, Kievit W, et al. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial. Lancet Gastroenterol Hepatol 2021; published online March 16, 10.1016/S2468-1253(21)00057-1. - DOI - PubMed

MeSH terms

Substances